Kissei Pharmaceutical Co., Ltd.
TSE:4547.T
3780 (JPY) • At close November 5, 2024
Overzicht | Financiële gegevens
Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) JPY.
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Omzet
| 75,579 | 67,493 | 65,381 | 69,044 | 63,245 | 72,302 | 73,998 | 71,707 | 71,297 | 70,108 | 70,400 | 62,494 | 64,669 | 64,387 | 62,137 | 64,538 | 61,475 | 64,179 | 64,013 | 60,938 |
Kosten van de omzet
| 41,155 | 35,118 | 34,143 | 36,321 | 28,340 | 26,735 | 25,878 | 25,076 | 23,582 | 24,063 | 23,182 | 21,146 | 22,899 | 22,492 | 21,718 | 23,722 | 22,796 | 27,983 | 28,288 | 23,530 |
Brutowinst
| 34,424 | 32,375 | 31,238 | 32,723 | 34,905 | 45,567 | 48,120 | 46,631 | 47,715 | 46,045 | 47,218 | 41,348 | 41,770 | 41,895 | 40,419 | 40,816 | 38,679 | 36,196 | 35,725 | 37,408 |
Brutowinstmarge
| 0.455 | 0.48 | 0.478 | 0.474 | 0.552 | 0.63 | 0.65 | 0.65 | 0.669 | 0.657 | 0.671 | 0.662 | 0.646 | 0.651 | 0.65 | 0.632 | 0.629 | 0.564 | 0.558 | 0.614 |
Onderzoek- en ontwikkelingskosten
| 9,474 | 10,391 | 10,363 | 9,626 | 10,767 | 15,711 | 14,179 | 13,877 | 14,106 | 14,488 | 11,298 | 10,312 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Algemene en administratieve kosten
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Verkoop- en marketingkosten
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Verkoop-, algemene en administratieve kosten
| 20,790 | 20,304 | 19,923 | 19,607 | 21,133 | 22,577 | 23,080 | 23,379 | 22,530 | 22,417 | 22,781 | 22,315 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Overige kosten
| -143 | 58 | 281 | 131 | 171 | 93 | 81 | 77 | 68 | 119 | 90 | 191 | 697 | 667 | 651 | 582 | 298 | 85 | 943 | 379 |
Bedrijfskosten
| 30,407 | 33,503 | 32,640 | 31,217 | 33,048 | 39,363 | 38,232 | 38,140 | 37,439 | 37,710 | 34,917 | 33,586 | 34,305 | 35,432 | 33,834 | 34,422 | 34,410 | 33,551 | 33,848 | 31,889 |
Bedrijfsresultaat
| 4,017 | -1,129 | -1,402 | 1,505 | 1,857 | 6,202 | 9,887 | 8,491 | 10,274 | 8,334 | 12,301 | 7,761 | 7,465 | 6,463 | 6,584 | 6,393 | 4,269 | 2,645 | 1,877 | 5,516 |
Bedrijfsresultaat ratio
| 0.053 | -0.017 | -0.021 | 0.022 | 0.029 | 0.086 | 0.134 | 0.118 | 0.144 | 0.119 | 0.175 | 0.124 | 0.115 | 0.1 | 0.106 | 0.099 | 0.069 | 0.041 | 0.029 | 0.091 |
Totaal overige inkomsten en kosten netto
| 10,432 | 14,822 | 17,908 | 5,970 | 2,772 | 917 | 1,809 | 1,625 | 861 | 2,131 | 1,099 | 230 | 609 | -131 | 31 | -3,036 | 202 | 528 | 1,710 | 2,461 |
Inkomen voor belasting
| 14,449 | 13,680 | 16,507 | 7,476 | 4,630 | 7,121 | 11,697 | 10,116 | 11,136 | 10,466 | 13,400 | 7,992 | 8,074 | 6,332 | 6,616 | 3,358 | 4,471 | 3,173 | 3,587 | 7,980 |
Inkomen voor belasting ratio
| 0.191 | 0.203 | 0.252 | 0.108 | 0.073 | 0.098 | 0.158 | 0.141 | 0.156 | 0.149 | 0.19 | 0.128 | 0.125 | 0.098 | 0.106 | 0.052 | 0.073 | 0.049 | 0.056 | 0.131 |
Belastingkosten
| 3,159 | 3,046 | 3,475 | 2,098 | 1,741 | 1,586 | 2,598 | 2,351 | 2,940 | 3,277 | 4,283 | 2,950 | 3,288 | 2,323 | 2,230 | 1,285 | 2,122 | 1,566 | 1,538 | 3,229 |
Nettowinst
| 11,160 | 10,528 | 12,921 | 5,285 | 2,817 | 5,481 | 9,045 | 7,726 | 8,165 | 7,165 | 9,093 | 5,019 | 4,769 | 4,004 | 4,371 | 2,061 | 2,325 | 1,571 | 2,045 | 4,734 |
Nettowinstmarge
| 0.148 | 0.156 | 0.198 | 0.077 | 0.045 | 0.076 | 0.122 | 0.108 | 0.115 | 0.102 | 0.129 | 0.08 | 0.074 | 0.062 | 0.07 | 0.032 | 0.038 | 0.024 | 0.032 | 0.078 |
WPA (Winst Per Aandeel)
| 246.58 | 228.3 | 280.19 | 113.25 | 60.3 | 117.33 | 188.24 | 158.74 | 166.89 | 142.14 | 176.67 | 97.52 | 91.35 | 73.78 | 80.52 | 37.98 | 42.86 | 28.93 | 37.31 | 86.47 |
Verwaterde WPA
| 246.58 | 228.3 | 280.19 | 113.25 | 60.3 | 117.33 | 188.24 | 158.74 | 166.89 | 142.14 | 176.67 | 97.52 | 91.35 | 73.78 | 80.52 | 37.16 | 40.16 | 28.93 | 37.31 | 75.53 |
EBITDA
| 8,271 | 4,628 | 4,134 | 5,933 | 5,817 | 9,975 | 13,542 | 11,804 | 13,633 | 12,033 | 15,385 | 11,038 | 10,828 | 10,002 | 10,524 | 10,912 | 8,704 | 6,113 | 6,047 | 9,028 |
EBITDA ratio
| 0.109 | 0.069 | 0.063 | 0.086 | 0.092 | 0.138 | 0.183 | 0.165 | 0.191 | 0.172 | 0.219 | 0.177 | 0.167 | 0.155 | 0.169 | 0.169 | 0.142 | 0.095 | 0.094 | 0.148 |